Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Remix Therapeutics in the transaction. Remix Therapeutics announced it closed its $60 million financing led by The Column Group. The...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Osmoses in the transaction. Osmoses announced its $11 million Series Seed financing led by Energy Capital Ventures, and included...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Lightmatter on the deal. Lightmatter, the leader in photonics, has announced that it raised a $154 million Series C investment round from SIP...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Kernal Biologics on the deal. Kernal Biologics, a Massachusetts-based biotech company, announced its $25 million Series A financing led by Hummingbird Ventures with participation...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised SumRidge Partners on the deal. SumRidge Partners, a financial services company, announced its acquisition by Raymond James Financial,...
You must be a Standard 1 Year member to access this content.
